Stockscreener 앱 받기
0.00
100.00%
-4.97
Bluebird Bio Inc 주식(BLUE)의 최신 뉴스
bluebird bio acquired to scale gene therapy access By Investing.com - Investing.com Canada
Carlyle, SK Capital close deal for bluebird bio, injecting capital for commercial expansion - The Business Journals
Carlyle, SK Capital Partners Close Bluebird Bio Acquisition - marketscreener.com
Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital - marketscreener.com
Bluebird Bio (BLUE) Acquired by Carlyle and SK Capital Partners | BLUE Stock News - GuruFocus
bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital | BLUE Stock News - GuruFocus
bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital - Business Wire
Carlyle, SK Capital Partners disclose expected closing date of bluebird bio deal - MSN
Carlyle and SK Capital to acquire bluebird bio By Investing.com - Investing.com South Africa
Northern Trust Corp Reduces Holdings in bluebird bio, Inc. (NASDAQ:BLUE) - Defense World
bluebird bio, Inc. (BLUE) Nears Acquisition by Carlyle and SK Capital - Insider Monkey
Bluebird Bio (BLUE) Acquisition Nears Completion - GuruFocus
Carlyle, SK Capital to close bluebird bio deal on June 2 - Seeking Alpha
Carlyle, SK Capital, Beacon Set To Close Bluebird Bio Acquisition - Nasdaq
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer - marketscreener.com
Carlyle-Led Group Closes Tender Offer for Bluebird Bio - marketscreener.com
Carlyle and SK Capital to acquire bluebird bio - Investing.com
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer | BLUE Stock News - GuruFocus
Bluebird Bio Beats Investor Suit Over FDA Cancer Warning - Law360
Bluebird Bio’s SWOT analysis: biotech firm’s stock faces merger crossroads By Investing.com - Investing.com India
Bluebird Bio’s SWOT analysis: biotech firm’s stock faces merger crossroads - Investing.com
Gene Therapy Death Worsens Picture for an Already Troubled Field - Barron's
bluebird bio Reminds Stockholders to Act Now to Tender Shares fo - GuruFocus
bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital - BioSpace
Bluebird Beats Investor Lawsuit Over FDA Black Box Warning (1) - Bloomberg Law News
High Noon For bluebird (NASDAQ:BLUE) - Seeking Alpha
PepGen Appoints New CTO with Bluebird Bio Experience | BLUE Stoc - GuruFocus
PepGen Appoints New CTO with Bluebird Bio Experience | BLUE Stock News - GuruFocus
Analysts Set bluebird bio, Inc. (NASDAQ:BLUE) Price Target at $44.60 - Defense World
Bluebird Beats Patent Case Over Blood Disease Therapies - Law360
Bluebird Wins Patent Fight Over Two High-Priced Gene Therapies - Bloomberg Law News
Dimensional Fund Advisors LP Sells 592,968 Shares of bluebird bio, Inc. (NASDAQ:BLUE) - Defense World
Tower Research Capital LLC TRC Reduces Stock Position in bluebird bio, Inc. (NASDAQ:BLUE) - Defense World
Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions - BioSpace
Carlyle, SK Capital Partners and bluebird bio Provide Updated Te - GuruFocus
Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions - marketscreener.com
Bluebird Bio's Acquisition Deal Offers Shareholders New Cash Option - Finimize
Beta thalassemia Market: Epidemiology, Therapies, Companies, - openPR.com
Bluebird Bio (BLUE) Reports Q1 Loss, Lags Revenue Estimates - MSN
bluebird bio updates terms of Carlyle, SK Capital buyout By Investing.com - Investing.com Canada
Carlyle and SK Capital boost Bluebird Bio bid, offering flexible payout terms - Private Equity Insights
bluebird bio (NASDAQ:BLUE) Coverage Initiated by Analysts at StockNews.com - Defense World
Bluebird: Q1 Earnings Snapshot - New Haven Register
Carlyle Group, SK Capital secure all regulatory approvals to acquire bluebird bio - MSN
Bluebird Bio (BLUE) Surges on Amended Deal with Carlyle and SK C - GuruFocus
bluebird bio, Inc. SEC 10-Q Report - TradingView
Bluebird, Private Equity Firms Look To Sweeten Buyout Deal - insights.citeline.com
0.87%
0.19%
자본화:
|
볼륨(24시간):